Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Click-crosslinked nanogels integrated into 3D stem cell spheroids enhance regenerative function for swallowing muscle repair.

Okuyama H., Brown M., Munipalle M., Nejati S., Huo R., Sakata H.

Animal Study on Face & Skin, published in Biomaterials (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Biomaterials (2026)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
41650592
DOI
10.1016/j.biomaterials.2026.124044

Abstract (original English)

Muscle injury or degeneration in the head and neck region can impair daily swallowing function. Mesenchymal stem cell (MSC) therapy has shown potential for muscle regeneration but faces challenges like poor cell survival and limited engraftment. Click-crosslinked nanogel-based hydrogels have emerged as promising cell delivery systems. This study introduces nanogel-microfiber fragments (NG-MF) as structural spacers within spheroids to enhance cell viability and function. By modifying cholesterol-bearing pullulan with acryloyl groups (CHPA) nanogels, we synthesized NG-MF using freeze-thaw cycles and sonication. NG-MF were then combined with adipose-derived MSCs (ADSCs) to fabricate hybrid spheroids. The NG-MF to ADSC ratio was optimized in hybrid spheroids, resulting in approximately a 5.6-fold increase in cell viability relative to cell-only spheroids. Hybrid spheroids also showed elevated secretion of key repair-associated factors, including interleukin (IL)-6, IL-10, and hepatocyte growth factor. This enhanced secretory function was maintained after the spheroids were refined to a smaller, injection-compatible size of approximately 100 μm for in vivo delivery. In rats with injured swallowing muscles, hybrid spheroid injection enhanced cell engraftment, reduced fibrosis, accelerated myogenin stabilization, and improved swallowing muscle function compared to cell-only spheroids.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsSpheroids, CellularRegenerationMesenchymal Stem CellsRatsGlucansPolyethyleneimineClick ChemistryCell SurvivalRats, Sprague-Dawley

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research